Results 151 to 160 of about 40,669 (305)

What Is Your Diagnosis? Blood Smear From a Mixed‐Breed Dog

Veterinary Clinical Pathology, EarlyView.
ABSTRACT A 10‐year‐old spayed female mixed‐breed dog was presented with a one‐week history of inappetence and hyperthermia. Blood smear evaluation revealed the presence of rare atypical cells, raising suspicion for a circulating neoplasm. Spleen cytology, histopathology, and immunohistochemistry confirmed the diagnosis of hemophagocytic histiocytic ...
Laura S. Peres, Lina C. Bilhalva, Camila B. E. Mello, Abílio G. Silva, Andrea P. Santos, Stella F. Valle   +5 more
wiley   +1 more source

Cytopenias as Adverse Drug Reactions: A 10-Year Analysis of Reporting Structure, Rate, and Trend. [PDF]

Pharmaceuticals (Basel)
Stević I, Janković SM, Mihailović M, Jović I, Odalović M, Marinković V, Lakić D.   +6 more
europepmc   +1 more source

Real‐world progression‐free survival and overall survival in patients with HR+/HER2− advanced breast cancer treated in first‐line with ribociclib, endocrine monotherapy or chemotherapy: Results from the observational RIBANNA study

International Journal of Cancer, Volume 159, Issue 1, Page 210-223, 1 July 2026.
What's New? The CDK4/6 inhibitor ribociclib in combination with an endocrine‐based therapy has demonstrated significant progression‐free and overall survival benefits in patients with advanced/metastatic HR+/HER2‐ breast cancer in the pivotal MONALEESA trials.
Peter A. Fasching, Cosima Brucker, Thomas Decker, Anne Engel, Thomas Göhler, Christian Jackisch, Jan Janssen, Andreas Köhler, Kerstin Lüdtke‐Heckenkamp, Diana Lüftner, Frederik Marmé, Marion van Mackelenbergh, Beate Rautenberg, Marcus Schmidt, Rudolf Weide, Pauline Wimberger, Elena Kisseleff, Christina Pfister, Claudia Quiering, Christian Roos, Achim Wöckel   +20 more
wiley   +1 more source

[Retracted] Uvangoletin induces mitochondria‑mediated apoptosis in HL‑60 cells <i>in vitro</i> and <i>in vivo</i> without adverse reactions of myelosuppression, leucopenia and gastrointestinal tract disturbances. [PDF]

Oncol Rep
Zheng Z, Qiao Z, Gong G, Wang Y, Zhang Y, Ma Y, Zhang L, Lu Y, Jiang B, Li G, Dong C, Chen W.   +11 more
europepmc   +1 more source

Oral lichenoid lesions in CTLA‐4 haploinsufficiency: Targeting IFN‐γ‐driven mucosal immunopathology

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Chen Wang, Laurie Brenchley, Teresa Greenwell‐Wild, Vasileios Ionas Theofilou, Timothy G. Myers, Chi A. Ma, Katherine Howe, Stefania Pittaluga, Steven M. Holland, Niki M. Moutsopoulos, David Fraser, Gulbu Uzel   +11 more
wiley   +1 more source

Meta-analysis of the efficacy and safety of Kanglaite Injection in conjunction with chemotherapy for cancer pain. [PDF]

Front Oncol
Feng G, Yi S, Chen R, Liu P, Li Y, Zhong Y, Peng Z, Liu Y, Xu S.   +8 more
europepmc   +1 more source

Evaluation of Hemoadsorption Capacity of the CytoSorb Adsorber for Toxic Doses of Diclofenac and Meloxicam in Porcine Plasma

Journal of Clinical Apheresis, Volume 41, Issue 3, June 2026.
ABSTRACT The objective of this in vitro experimental was to determine the utility of hemoadsorption (HA) using the CytoSorb adsorber to remove meloxicam and diclofenac from porcine plasma. For this purpose 12 1‐L aliquots of porcine plasma, 6 units were spiked with 293 μg/mL (262–320 μg/mL) diclofenac and 6 with 42.8 μg/mL (41.4–44.7 μg/mL) meloxicam ...
Bettina Giani, René Dörfelt, Katrin Hartmann, Florian Sänger   +3 more
wiley   +1 more source

The impact of sequential chemoradiotherapy versus concurrent chemoradiotherapy on prognosis in adjuvant treatment after radical hysterectomy for cervical cancer. [PDF]

World J Surg Oncol
Ma Y, Shi S.
europepmc   +1 more source

Efficacy and Safety of Azacitidine Combined With Lisaftoclax in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome With Increased Blasts

eJHaem, Volume 7, Issue 3, June 2026.
ABSTRACT Objective To retrospectively analyze the early efficacy and safety of azacitidine plus lisaftoclax in patients with acute myeloid leukemia (AML) and myelodysplastic syndrome with increased blasts (MDS‐IB), providing a reliable clinical reference.
Shan Meng, Wanhong Zhao, Hui Zhang, Bo Lei, Wanggang Zhang, Yilin Zhang, Jin Wang, Yinxia Chen, Xingmei Cao, Liufang Gu   +9 more
wiley   +1 more source

[Systemic infection caused by <i>Magnusiomyces</i> spp. in oncohaematological patients]. [PDF]

Rev Esp Quimioter
Vargas-Herrera AI, Bolaños-Rivero M, Pisos-Álamo E, de-Miguel-Martínez I.   +3 more
europepmc   +1 more source